pancreatic cancer
Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium
Investigators are assessing performance in a prospective cohort with hopes that the method can be used to complement currently used imaging surveillance.
Immunovia to Restructure Operations, Lay Off Employees
The firm said it will stop commercialization of its ImmRay PanCan-d test in the US to focus on developing its next-generation pancreatic cancer detection test.
Interpace Biosciences to Stop Offering Pancreatic Cancer Test After Losing CMS Reimbursement
Novitas said in its coverage determination that the test has not demonstrated incremental clinical value in the prognosis of pancreatic cysts and associated cancer.
Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening Test
The partners will collaborate to develop novel microbiome biomarkers for a screening test in development called PancAlert.
NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test
The collaboration will test retrospective samples from more than 200 patients to validate Biological Dynamics' platform.
Oct 11, 2022
Apr 22, 2021